RG 7166Alternative Names: RG-7166
Latest Information Update: 25 Mar 2017
At a glance
- Originator Roche
- Class Antidepressants
- Mechanism of Action Adrenergic uptake inhibitors; Dopamine uptake inhibitors; Serotonin uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 01 Feb 2012 Discontinued - Phase-I for Major depressive disorder (unspecified route)
- 31 Dec 2009 Phase-I clinical trials in Depression (unspecified route)